XML 43 R31.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS AND GOODWILL (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of indefinite-lived intangible assets
The major components of intangible assets consist of:
 June 30, 2023December 31, 2022
(in millions)
Gross
Carrying
Amount
Accumulated
Amortization and Impairments
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization and Impairments
Net
Carrying
Amount
Finite-lived intangible assets:
      
Product brands$2,726 $(2,466)$260 $2,650 $(2,373)$277 
Corporate brands12 (8)12 (7)
Product rights/patents993 (939)54 992 (919)73 
Technology and other67 (62)66 (61)
Total finite-lived intangible assets3,798 (3,475)323 3,720 (3,360)360 
B&L Trademark1,698 — 1,698 1,698 — 1,698 
$5,496 $(3,475)$2,021 $5,418 $(3,360)$2,058 
Schedule of finite-lived intangible assets
The major components of intangible assets consist of:
 June 30, 2023December 31, 2022
(in millions)
Gross
Carrying
Amount
Accumulated
Amortization and Impairments
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization and Impairments
Net
Carrying
Amount
Finite-lived intangible assets:
      
Product brands$2,726 $(2,466)$260 $2,650 $(2,373)$277 
Corporate brands12 (8)12 (7)
Product rights/patents993 (939)54 992 (919)73 
Technology and other67 (62)66 (61)
Total finite-lived intangible assets3,798 (3,475)323 3,720 (3,360)360 
B&L Trademark1,698 — 1,698 1,698 — 1,698 
$5,496 $(3,475)$2,021 $5,418 $(3,360)$2,058 
Schedule of estimated aggregate amortization expense for each of the five succeeding years
Estimated amortization expense of finite-lived intangible assets for the remainder of 2023 and the five succeeding years ending December 31 and thereafter are as follows:
(in millions)Remainder of 202320242025202620272028ThereafterTotal
Amortization$77 $97 $51 $18 $17 $17 $46 $323 
Schedule of changes in the carrying amount of goodwill
The changes in the carrying amounts of goodwill during the six months ended June 30, 2023 and the year ended December 31, 2022 were as follows:
(in millions)Vision CarePharmaceuticalsSurgicalTotal
Balance, January 1, 2022$3,596 $675 $315 $4,586 
Acquisitions (Note 5)— — 
Foreign exchange and other(47)(30)(7)(84)
Balance, December 31, 20223,549 645 313 4,507 
Acquisitions (Note 5)— — 
Foreign exchange and other16 25 
Balance, June 30, 2023
$3,555 $661 $324 $4,540